InvestorsHub Logo
Followers 828
Posts 119328
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 731

Wednesday, 10/20/2021 2:33:04 PM

Wednesday, October 20, 2021 2:33:04 PM

Post# of 800
ABT has essentially restored its 2021 non-GAAP EPS guidance from Apr 2021, which was $5.00+. In April, ABT expected 2021 COVID-diagnostics sales of $6.0-6.5B. In June, ABT lowered EPS guidance and reduced its expectation for 2021 COVID-19 sales to $4.0-4.5B (#msg-164129735) because COVID testing declined precipitously.

Then, the COVID Delta variant came calling. Now, it looks like ABT’s original forecast of $6.0-6.5B in 2021 COVID-diagnostic sales will be met after all, insofar as sales for the first 9 months of the year have been $5.4B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News